Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells
Year: 2023
Type: article
Source: Anti-Cancer Drugs
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4386701655
